The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Silicon Laboratories Inc

Nasdaq: SLAB
Last

(U.S.) $55.31

Today's change0.00 0.00%
Updated June 2 4:00 PM EDT. Delayed by at least 15 minutes.
 

Silicon Laboratories Inc

Nasdaq: SLAB
Last

(U.S.) $55.31

Today's change0.00 0.00%
Updated June 2 4:00 PM EDT. Delayed by at least 15 minutes.

Silicon Laboratories Inc closed at (U.S.)$55.31.

Over the last five days, shares have gained 5.33% and are currently 1.21% off of the 52-week high. Shares have outperformed the S&P 500 by 14.39% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $55.31
  • High--
  • Low--
  • Bid / Ask(U.S.) $50.60 / (U.S.) $60.10
  • YTD % change+16.15%
  • Volume0
  • Average volume (10-day)324,303
  • Average volume (1-month)310,736
  • Average volume (3-month)289,457
  • 52-week range(U.S.) $36.29 to (U.S.) $55.99
  • Beta1.00
  • Trailing P/E66.37×
  • P/E 1 year forward24.06×
  • Forward PEG3.44×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.83
Updated June 2 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+5.68%

Based on its net profit margin of 5.68%, Silicon Laboratories Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:TechnologyIndustry:Semiconductors
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedApr 04, 201504/04/2015Jan 03, 201501/03/2015Sep 27, 201409/27/2014Jun 28, 201406/28/2014
Revenue164162158155
Total other revenue--------
Total revenue164162158155
Gross profit96979699
Total cost of revenue67656256
Total operating expense156151149134
Selling / general / administrative42404436
Research & development47464342
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income7111021
Interest income (expense), net non-operating-1-1-1-1
Gain (loss) on sale of assets--------
Other--------
Income before tax710920
Income after tax610614
Income tax, total1046
Net income610614
Total adjustments to net income--------
Net income before extra. items610614
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items610614
Inc. avail. to common incl. extra. items610614
Diluted net income610614
Dilution adjustment----0--
Diluted weighted average shares43434444
Diluted EPS excluding extraordinary itemsvalue per share0.150.230.130.32
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.150.230.130.32